DENTSPLY SIRONA Inc (XRAY) Holdings Lessened by Bbva Compass Bancshares Inc.

Bbva Compass Bancshares Inc. trimmed its holdings in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 13.9% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,963 shares of the medical instruments supplier’s stock after selling 1,925 shares during the period. Bbva Compass Bancshares Inc.’s holdings in DENTSPLY SIRONA were worth $451,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Continental Advisors LLC raised its position in shares of DENTSPLY SIRONA by 60.6% in the 2nd quarter. Continental Advisors LLC now owns 92,800 shares of the medical instruments supplier’s stock valued at $4,062,000 after purchasing an additional 35,000 shares in the last quarter. Bank of Montreal Can raised its position in shares of DENTSPLY SIRONA by 65.8% in the 3rd quarter. Bank of Montreal Can now owns 388,396 shares of the medical instruments supplier’s stock valued at $14,658,000 after purchasing an additional 154,125 shares in the last quarter. Nuance Investments LLC raised its position in shares of DENTSPLY SIRONA by 134.6% in the 2nd quarter. Nuance Investments LLC now owns 2,174,311 shares of the medical instruments supplier’s stock valued at $95,170,000 after purchasing an additional 1,247,670 shares in the last quarter. Strs Ohio raised its position in shares of DENTSPLY SIRONA by 28.4% in the 2nd quarter. Strs Ohio now owns 386,886 shares of the medical instruments supplier’s stock valued at $16,934,000 after purchasing an additional 85,558 shares in the last quarter. Finally, QUANTRES ASSET MANAGEMENT Ltd acquired a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at approximately $577,000. 97.90% of the stock is currently owned by institutional investors.

Shares of NASDAQ XRAY opened at $36.80 on Friday. DENTSPLY SIRONA Inc has a twelve month low of $33.93 and a twelve month high of $68.98. The company has a quick ratio of 1.10, a current ratio of 1.69 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $7.90 billion, a PE ratio of 13.83, a PEG ratio of 2.06 and a beta of 1.15.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, November 8th. The medical instruments supplier reported $0.38 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.46 by ($0.08). DENTSPLY SIRONA had a negative net margin of 39.62% and a positive return on equity of 9.12%. The firm had revenue of $928.40 million during the quarter, compared to the consensus estimate of $951.58 million. During the same quarter last year, the firm posted $0.70 earnings per share. DENTSPLY SIRONA’s revenue was down 8.0% compared to the same quarter last year. On average, equities analysts forecast that DENTSPLY SIRONA Inc will post 2.07 EPS for the current year.

A number of brokerages have issued reports on XRAY. Zacks Investment Research lowered DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Monday, August 6th. Robert W. Baird lowered DENTSPLY SIRONA from an “outperform” rating to a “neutral” rating and cut their target price for the company from $56.00 to $38.00 in a research report on Tuesday, August 7th. BidaskClub raised DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Tuesday, July 31st. Barrington Research lowered DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, August 9th. Finally, HC Wainwright set a $40.00 target price on DENTSPLY SIRONA and gave the company a “hold” rating in a research report on Friday, August 31st. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the company’s stock. DENTSPLY SIRONA currently has an average rating of “Hold” and a consensus price target of $51.50.

TRADEMARK VIOLATION WARNING: This piece of content was originally posted by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this piece of content on another website, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at https://sportsperspectives.com/2018/11/09/dentsply-sirona-inc-xray-holdings-lessened-by-bbva-compass-bancshares-inc.html.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Featured Story: How to Use a Moving Average for Trading 

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply